This scoping review synthesises evidence on the carbon footprint of clinical trials, identifying trial-related travel, meetings, facilities, and laboratory activities as the most carbon-intensive components. With health research itself generating substantial emissions, and reducing those emissions a stated strategic priority for health systems in multiple countries, this review identifies research gaps and emphasizes the need for standardized approaches to measuring and reducing trial carbon footprints.